Free Trial

First Citizens Bank & Trust Co. Acquires 13,974 Shares of Genpact Limited $G

Genpact logo with Computer and Technology background

Key Points

  • First Citizens Bank & Trust Co. increased its stake in Genpact Limited by 259.2%, purchasing an additional 13,974 shares, bringing its total holdings to 19,365 shares worth approximately $852,000.
  • Insider transactions noted include SVP Piyush Mehta selling 76,902 shares and CEO Balkrishan Kalra offloading 55,000 shares, indicating a decrease in their respective holdings.
  • Equities analysts have set a new consensus target price of $51.13 for Genpact, with Mizuho and Needham increasing their price targets to $51.00 and $53.00 respectively.
  • Interested in Genpact? Here are five stocks we like better.

First Citizens Bank & Trust Co. lifted its holdings in Genpact Limited (NYSE:G - Free Report) by 259.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,365 shares of the business services provider's stock after purchasing an additional 13,974 shares during the period. First Citizens Bank & Trust Co.'s holdings in Genpact were worth $852,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Cornerstone Planning Group LLC acquired a new stake in shares of Genpact in the first quarter worth about $27,000. Richardson Financial Services Inc. bought a new position in shares of Genpact in the 1st quarter valued at approximately $35,000. Steph & Co. acquired a new stake in Genpact in the 2nd quarter worth approximately $37,000. SVB Wealth LLC bought a new stake in Genpact during the first quarter worth approximately $41,000. Finally, Kestra Investment Management LLC acquired a new position in Genpact during the first quarter valued at approximately $56,000. 96.03% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Genpact news, SVP Piyush Mehta sold 76,902 shares of Genpact stock in a transaction on Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the sale, the senior vice president owned 134,880 shares in the company, valued at $5,743,190.40. The trade was a 36.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Balkrishan Kalra sold 55,000 shares of the business's stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the sale, the chief executive officer directly owned 295,246 shares in the company, valued at $12,801,866.56. This trade represents a 15.70% decrease in their position. The disclosure for this sale can be found here. Insiders own 3.07% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Mizuho lifted their price target on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research report on Tuesday, July 1st. Needham & Company LLC lifted their target price on shares of Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Weiss Ratings restated a "hold (c)" rating on shares of Genpact in a report on Wednesday, October 8th. Wall Street Zen lowered Genpact from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Finally, Citigroup raised Genpact to a "hold" rating in a research report on Thursday. Three research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $51.13.

Get Our Latest Report on G

Genpact Stock Performance

NYSE:G opened at $39.48 on Friday. The firm's 50-day moving average is $42.29 and its 200-day moving average is $43.95. The company has a market cap of $6.88 billion, a price-to-earnings ratio of 13.11, a PEG ratio of 1.37 and a beta of 0.89. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53. Genpact Limited has a 52-week low of $37.82 and a 52-week high of $56.76.

Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The business had revenue of $1.25 billion during the quarter, compared to analysts' expectations of $1.23 billion. During the same quarter last year, the company earned $0.79 earnings per share. The firm's revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Equities research analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, December 9th will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, December 9th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.7%. Genpact's payout ratio is currently 22.59%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Markets Are Sliding: Where to Find Opportunity

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines